Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Meldola FC
Clinical trial register · Italy

Clinical Trials in Meldola FC, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6793 matching records held by the registry are in this view. Synced 17 Nov 2026, 03:20 UTC
6793
Studies in scope
all four open statuses
4085
Recruiting now
open to new participants
1016
Lead sponsors
across recruiting studies
Top sites
Milan 2856 Bologna 1286 Roma 1267 Naples 984 Rome 970

Trials with a site in Meldola FC

26 of 6793 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Boehringer Ingelheim
Phase 3
670
Aviano (PN), Bari, Brescia, Florence, Meldola (FC), Orbassano (TO), Padova, Parma
2026-04-13
Recruiting
Nurix Therapeutics, Inc.
Phase 2
100
Alessandria, Bologna, Brescia, Meldola (FC), Milan, Ravenna
2025-10-15
Active, closed
Amgen
Phase 3
350
Bari, Bergamo, Meldola (FC), Milan, Roma, Verona
2025-08-18
Recruiting
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
NCT06517875Primary Myelofibrosis, Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis
GlaxoSmithKline
Phase 2
68
Milan, Bologna, Catania, Florence, Meldola FC, Roma
2025-02-28
Active, closed
Pfizer
Phase 3
1,035
Bologna, Meldola(FC), Rome, Florence, Milan, Novara, Padova, Roma
2025-01-06
Recruiting
Boehringer Ingelheim
Phase 2
588
Ancona, Aviano (PN), Meldola (FC), Milan, Naples, Rome
2024-10-11
Recruiting
Amgen
Phase 3
450
Brescia, Castellana Grotte, Florence, Foggia, Genova, Meldola FC, Milan, Naples
2024-07-17
Recruiting
Boehringer Ingelheim
Phase 1/2
910
Ancona, Candiolo (TO), Meldola (FC), Milan, Misterbianco (CT), Naples, Rozzano
2024-06-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Naples, Misterbianco, Meldola (FC), Aviano, Rome, Brescia, Milan, Monza
2024-06-24
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
762
Meldola (Fc), Milan, Monza, Genova, Brescia, Roma, Ancona, Aviano (PN)
2024-02-21
Active, closed
Amgen
Phase 3
509
Bergamo, Catanzaro, Genova, Meldola (FC), Orbassano, Roma
2023-05-31
Active, closed
Celgene
Phase 3
313
Meldola (fc), Ancona, Bologna, Brescia, Catania, Florence, Milan, Napoli Campania
2021-02-25
Active, closed
Incyte Corporation
Phase 2
112
Bologna, Florence, Meldola (FC), Milan, Naples, Novara, Palermo, Pisa
2020-08-03
Recruiting
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Not applicable
60,000
Meldola (FC), Florence, Forlì, Torino
2020-02-06
Active, closed
GlaxoSmithKline
Phase 1
118
Bologna, Meldola FC
2019-12-18
Active, closed
Tesaro, Inc.
Phase 3
1,400
Bologna, Faenza, Lugo RA, Meldola FC, Naples
2018-10-11
Recruiting
Xynomic Pharmaceuticals, Inc.
Phase 3
413
Candiolo, Catania, Meldola (FC), Milan, Naples, Novara, Pavia, Pisa
2018-07-17
Active, closed
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
NCT03485209Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Exocrine Pancreatic Cancer, Carcinoma, Squamous Cell of Head and Neck
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
350
Meldola (Fc), Ravenna, Meldola (FC), Rome, Brescia, Milan, Cattolica, Rimini
2018-06-25
Active, closed
Pfizer
Phase 3
1,068
Naples, Roma, Cremona, Faenza RA, Lugo RA, Meldola (FC), Orbassano (TO), Ravenna
2014-12-17
Rows per page Showing 1–26 of 26
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 19 November 2026. https://priyalifescience.com/clinical-trials-italy/city/meldola-fc

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,793 studies in total at the last sync on 17 Nov 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 26 of those studies with a site in Meldola FC.

How many clinical trials are recruiting in Meldola FC?

12 of the 26 studies on this page are recruiting new participants as of the 17 Nov 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 14 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Meldola FC), 26 studies
PhaseStudiesRecruitingShare
Phase 316761.5%
Phase 25319.2%
Phase 13011.5%
Not applicable113.8%
Phase 1/2113.8%

Most active sponsors

Lead sponsors with the most studies (Meldola FC)
Lead sponsorStudiesRecruiting
Amgen52
GlaxoSmithKline52
Boehringer Ingelheim43
Pfizer31
Seagen, a wholly owned subsidiary of Pfizer20
Celgene10
Incyte Corporation10
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS11
Merck Sharp & Dohme LLC11
Nurix Therapeutics, Inc.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.